Corrigendum to "Age-related bone loss and sarcopenia in men" [Maturitas 122 (2019) 51-56]
- PMID: 34844791
- DOI: 10.1016/j.maturitas.2021.11.010
Corrigendum to "Age-related bone loss and sarcopenia in men" [Maturitas 122 (2019) 51-56]
Conflict of interest statement
MRL has received consultancy fees from UCB (related to romosozumab), travel support and lecture fees from Amgen, and consultancy fees from Alexion, Kyowa Kirin and Sandoz, unrelated to this work. EG has received consultancy fees from UCB (related to romosozumab) and non-financial support from Amgen unrelated to this work. All other authors have nothing to disclose.
Erratum for
-
Age-related bone loss and sarcopenia in men.Maturitas. 2019 Apr;122:51-56. doi: 10.1016/j.maturitas.2019.01.006. Epub 2019 Jan 23. Maturitas. 2019. PMID: 30797530 Review.
Publication types
LinkOut - more resources
Full Text Sources
